«Macrophages

Below is an extended Macrophages patents listing. Click here to return to the Macrophages main in depth entry.

Patents :
US Patent No.	Title
7427495	Methods of using Bcl-2 for the therapeutic treatment and prevention of diseases
7427662	Inhibition of angiogenesis and destruction of angiogenic vessels by apolipoprotein A-I and high density lipoprotein
7427665	Chronic lymphocytic leukemia cell line
7427667	PRO9835 antibodies
7427668	Antibodies binding the TNF related protein, TNF-Y
7427669	ULBP antibodies
7427689	ErbB-2 selective small molecule kinase inhibitors
7429249	Method for cavitation-induced tissue healing with low intensity ultrasound
7429374	Process for the measurement of the potency of glatiramer acetate
7429376	Methods of screening for compounds that improve engraftment
7429378	Transdiscal administration of high affinity anti-MMP inhibitors
7427661	Canine IL-5 proteins and fragments thereof
7427657	Aromatic sulfenates for type 1 phototherapy
7427655	Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid .beta. for induction of an immune response to amyloid .beta. and amyloid deposits
7427589	Use of cytokine inhibitors
7427591	Suppression of immune response via inhibition of cathepsin S
7427595	Use of proepithelin to promote wound repair and reduce inflammation
7427602	Sustained DNA delivery from structural matrices
7427603	Method of enhancing proliferation and/or hematopoietic differentiation of stem cells
7427605	Inhibitors of ribonucleotide reductase subunit 2 and uses thereof
7427606	Method to reduce inflammatory response in transplanted tissue
7427625	Substituted thiatriazaacenaphthylene-6-carbonitrile kinase inhibitors
7427628	Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha..sub.4 integrins
7427631	Metalloproteinase inhibitors
7429379	TNF receptor action modulation
7429383	Parathyroid hormone receptor activation and hematopoietic progenitor cell expansion
7429612	Indoline compound and medicinal use thereof
7429614	Medicament containing an effector of the glutathione metabolism together with .alpha.-lipoic acid for treating diabetes mellitus
7429639	SSX-2 peptides presented by HLA class II molecules
7429640	PRO6181 polypeptides
7429641	PRO9830 polypeptides
7429643	POSH nucleic acids, polypeptides and related methods
7429646	Antibodies to human tumor necrosis factor receptor-like 2
7429653	Stabilized soluble glycoprotein trimers
7429666	Pyridine analogs as C5a antagonists
7429690	Transgenic bovines having reduced prion protein production
7429611	Indole inhibitors of 15-lipoxygenase
7429599	Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
7429596	1H-pyrrolo [2,3-D] pyrimidine derivatives and methods of use thereof
7429384	Chimeric antagonist anth1
7429457	Id-1 and Id-2 genes and products as markers of epithelial cancer
7429460	Methods of screening for inhibitors of phospholipid synthesis related to glycolipid-storage diseases
7429461	Genetic products differentially expressed in tumors and use thereof
7429481	Targeting viruses using a modified sindbis glycoprotein
7429489	Methods of controlling proliferation and differentiation of stem and progenitor cells
7429564	Oral insulin therapy
7429570	Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
7429591	Substituted pyrazoles
7429594	Substituted heterocyclic compounds and methods of use
7430476	Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.